VolitionRX (VNRX) Stock Statistics & Valuation Metrics

VolitionRX has a market cap or net worth of $7.34M. The enterprise value is $19.60.

VolitionRX has 13,649,384 shares outstanding. The number of shares has decreased by -2.65% in one year.

VolitionRX’s return on equity (ROE) is 0.68 and return on invested capital (ROIC) is 1236.74%.

The current PE Ratio of VolitionRX is ―. VolitionRX’s PEG ratio is 0.04.

In the last 12 months, VolitionRX had revenue of 1.73M and earned -23.36M in profits. Earnings per share was -4.40.

In the last 12 months, operating cash flow was -19.40M and capital expenditures -20.79K, giving a free cash flow of -19.43M billion.

VolitionRX pays an annual dividend of ―, resulting in a dividend yield of ―

VolitionRX upcoming earnings date is Nov 12, 2026, After Close (Confirmed).

VolitionRX as a current ratio of 0.17, with Debt / Equity ratio of -8.82%

In the past 12 months, VolitionRX has paid 0.00 in taxes.

VolitionRX EV to EBITDA ratio is -1.90, with an EV/FCF ratio of -1.90.

VolitionRX has $2.79M in cash and marketable securities with $1.77M in debt, giving a net cash position of $1.02M billion.

Gross margin is 89.65%, with operating margin of -1228.57%, and net profit margin of -1352.16%.

The average price target for VolitionRX is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy